JP2021046398A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021046398A5 JP2021046398A5 JP2020182295A JP2020182295A JP2021046398A5 JP 2021046398 A5 JP2021046398 A5 JP 2021046398A5 JP 2020182295 A JP2020182295 A JP 2020182295A JP 2020182295 A JP2020182295 A JP 2020182295A JP 2021046398 A5 JP2021046398 A5 JP 2021046398A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- composition
- use according
- patients
- amh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 11
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 claims 9
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 claims 9
- 229940028334 follicle stimulating hormone Drugs 0.000 claims 9
- 208000000509 infertility Diseases 0.000 claims 7
- 230000036512 infertility Effects 0.000 claims 7
- 231100000535 infertility Toxicity 0.000 claims 7
- 230000037396 body weight Effects 0.000 claims 6
- 210000002966 serum Anatomy 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000009450 sialylation Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17189119 | 2017-09-01 | ||
| EP17189119.5 | 2017-09-01 | ||
| JP2020512546A JP6856819B2 (ja) | 2017-09-01 | 2018-08-31 | 調節卵巣刺激のための組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512546A Division JP6856819B2 (ja) | 2017-09-01 | 2018-08-31 | 調節卵巣刺激のための組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021046398A JP2021046398A (ja) | 2021-03-25 |
| JP2021046398A5 true JP2021046398A5 (enExample) | 2021-10-07 |
| JP7373479B2 JP7373479B2 (ja) | 2023-11-02 |
Family
ID=59772482
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512546A Active JP6856819B2 (ja) | 2017-09-01 | 2018-08-31 | 調節卵巣刺激のための組成物 |
| JP2020182295A Active JP7373479B2 (ja) | 2017-09-01 | 2020-10-30 | 調節卵巣刺激のための組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512546A Active JP6856819B2 (ja) | 2017-09-01 | 2018-08-31 | 調節卵巣刺激のための組成物 |
Country Status (32)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI846743B (zh) | 2018-10-17 | 2024-07-01 | 荷蘭商菲林公司 | 用於控制性卵巢刺激之組成物及方法 |
| TW202237173A (zh) * | 2020-12-09 | 2022-10-01 | 荷蘭商菲林公司 | 用於受控的卵巢刺激之組成物及方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA004924B1 (ru) * | 2000-01-27 | 2004-10-28 | Апплайд Резеч Системз Арс Холдинг Н.В. | Способ лечения бесплодия у женщин с использованием фолликулостимулирующего гормона |
| US20040248784A1 (en) | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
| ES2494928T3 (es) * | 2007-09-21 | 2014-09-16 | Pharmabrand S.A. | Composición que comprende polisacáridos mucilaginosos derivados de Aloe barbadensis combinados con liposomas, procedimiento para la obtención de los mismos y su uso como protector solar, un agente antiacné, un regenerador epidérmico y un hidratante |
| TWI488640B (zh) | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
| EP2526111A2 (en) * | 2010-01-21 | 2012-11-28 | Ramot at Tel Aviv University, Ltd. | Aloe-emodin derivatives and use thereof for the treatment of cancer |
| US9320778B2 (en) | 2010-09-29 | 2016-04-26 | Ferring B.V. | Method for controlled ovarian stimulation with combined FSH and hCG |
| WO2012168680A1 (en) | 2011-06-06 | 2012-12-13 | Ferring B.V. | Pharmaceutical preparation comprising recombinant fsh |
| JO3092B1 (ar) * | 2011-08-08 | 2017-03-15 | Ferring Bv | مركب لتحفيز مسيطر عليه للمبيض |
| SG11201608132UA (en) * | 2014-04-18 | 2016-11-29 | Glycotope Gmbh | Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone |
| AU2016223496B2 (en) | 2015-02-26 | 2021-09-09 | Ferring B.V. | Methods of treating infertility |
| ES2784625T3 (es) | 2015-04-17 | 2020-09-29 | Ferring Bv | FSH para el tratamiento de la infertilidad |
| MD3286209T2 (ro) | 2015-04-24 | 2021-04-30 | Ferring Bv | Metodă de producere a gonadotrofinei |
| JP6845813B2 (ja) | 2015-06-26 | 2021-03-24 | フェリング ベスローテン フェンノートシャップ | 精製および／またはウイルス不活性化の方法 |
| SI3787667T1 (sl) | 2018-04-30 | 2025-06-30 | Ferring B.V. | Sestavek za nadzorovano stimulacijo jajčnikov |
| TWI846743B (zh) | 2018-10-17 | 2024-07-01 | 荷蘭商菲林公司 | 用於控制性卵巢刺激之組成物及方法 |
-
2018
- 2018-08-31 EP EP24181981.2A patent/EP4427806A3/en active Pending
- 2018-08-31 ES ES18768795T patent/ES2904787T3/es active Active
- 2018-08-31 CN CN201880055934.1A patent/CN111050787A/zh active Pending
- 2018-08-31 TW TW107130683A patent/TWI749255B/zh active
- 2018-08-31 MY MYPI2020000971A patent/MY200791A/en unknown
- 2018-08-31 PL PL18768795T patent/PL3675894T3/pl unknown
- 2018-08-31 CA CA3073624A patent/CA3073624A1/en active Pending
- 2018-08-31 IL IL272763A patent/IL272763B2/en unknown
- 2018-08-31 MD MDE20220351T patent/MD3973982T2/ro unknown
- 2018-08-31 KR KR1020257016376A patent/KR20250078595A/ko active Pending
- 2018-08-31 PL PL21196378.0T patent/PL3973982T3/pl unknown
- 2018-08-31 DK DK18768795.9T patent/DK3675894T3/da active
- 2018-08-31 FI FIEP21196378.0T patent/FI3973982T3/fi active
- 2018-08-31 RS RS20220042A patent/RS62810B1/sr unknown
- 2018-08-31 SI SI201830484T patent/SI3675894T1/sl unknown
- 2018-08-31 LT LTEPPCT/EP2018/073442T patent/LT3675894T/lt unknown
- 2018-08-31 KR KR1020207009105A patent/KR20200045543A/ko not_active Ceased
- 2018-08-31 SI SI201831147T patent/SI3973982T1/sl unknown
- 2018-08-31 CN CN202510833422.5A patent/CN120617484A/zh active Pending
- 2018-08-31 EP EP18768795.9A patent/EP3675894B1/en active Active
- 2018-08-31 DK DK21196378.0T patent/DK3973982T3/da active
- 2018-08-31 HU HUE18768795A patent/HUE056726T2/hu unknown
- 2018-08-31 MA MA56224A patent/MA56224B1/fr unknown
- 2018-08-31 MD MDE20200700T patent/MD3675894T2/ro unknown
- 2018-08-31 PT PT187687959T patent/PT3675894T/pt unknown
- 2018-08-31 US US16/642,777 patent/US11744879B2/en active Active
- 2018-08-31 WO PCT/EP2018/073442 patent/WO2019043143A1/en not_active Ceased
- 2018-08-31 MA MA50034A patent/MA50034B1/fr unknown
- 2018-08-31 LT LTEP21196378.0T patent/LT3973982T/lt unknown
- 2018-08-31 ES ES21196378T patent/ES2989511T3/es active Active
- 2018-08-31 UA UAA202002175A patent/UA126869C2/uk unknown
- 2018-08-31 HR HRP20211802TT patent/HRP20211802T1/hr unknown
- 2018-08-31 AR ARP180102492 patent/AR112541A1/es unknown
- 2018-08-31 RS RS20241007A patent/RS65945B1/sr unknown
- 2018-08-31 HU HUE21196378A patent/HUE068024T2/hu unknown
- 2018-08-31 JO JOP/2020/0034A patent/JOP20200034A1/ar unknown
- 2018-08-31 JP JP2020512546A patent/JP6856819B2/ja active Active
- 2018-08-31 BR BR112020003379-0A patent/BR112020003379A2/pt unknown
- 2018-08-31 MX MX2020002235A patent/MX2020002235A/es unknown
- 2018-08-31 SG SG11202003840QA patent/SG11202003840QA/en unknown
- 2018-08-31 EP EP21196378.0A patent/EP3973982B1/en active Active
- 2018-08-31 PT PT211963780T patent/PT3973982T/pt unknown
- 2018-08-31 HR HRP20241171TT patent/HRP20241171T1/hr unknown
- 2018-08-31 EA EA202090480A patent/EA202090480A1/ru unknown
- 2018-08-31 AU AU2018326556A patent/AU2018326556B2/en active Active
-
2020
- 2020-02-27 CL CL2020000482A patent/CL2020000482A1/es unknown
- 2020-02-27 MX MX2024009224A patent/MX2024009224A/es unknown
- 2020-02-28 PH PH12020500404A patent/PH12020500404A1/en unknown
- 2020-10-30 JP JP2020182295A patent/JP7373479B2/ja active Active
-
2023
- 2023-07-25 US US18/226,206 patent/US20240024424A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019511488A5 (enExample) | ||
| JP2018513188A5 (enExample) | ||
| JP2016516016A5 (enExample) | ||
| JP2008520544A5 (ja) | 癌関連疲労の治療または予防のための医薬の製造への使用方法 | |
| IL307966A (en) | Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug | |
| CN106581641B (zh) | 一种多肽在预防或治疗心肌缺血再灌注损伤相关疾病中的药物应用 | |
| JP2021046398A5 (enExample) | ||
| Prevention Committee of the Japanese Society for Tuberculosis et al. | Treatment guidelines for latent tuberculosis infection | |
| JP2019530713A5 (enExample) | ||
| JP2018519366A5 (enExample) | ||
| Godoy et al. | Is a second cycle of immunoglobulin justified in axonal forms of Guillain-Barré syndrome? | |
| JP2020500864A5 (enExample) | ||
| JP2014508758A5 (enExample) | ||
| JP2025072354A (ja) | チルゼパチド治療方法 | |
| WO2021199006A1 (en) | Anti-cd6 antibody compositions and methods for treating and reducing negative effects of a coronavirus including covid-19 | |
| JP2020526525A5 (enExample) | ||
| JP2021004249A5 (enExample) | ||
| JP2007501806A5 (enExample) | ||
| Absher et al. | Aggravation of myasthenia gravis by erythromycin | |
| EP3393517B1 (en) | Acetylsalicylic acid for use in the treatment of moderate to severe influenza | |
| CN115884774A (zh) | 冠状病毒感染症治疗剂 | |
| JP2005529152A5 (enExample) | ||
| FI3973982T3 (fi) | Koostumus munasarjojen kontrolloituun stimulaatioon | |
| Hu et al. | Therapeutic plasma exchange combined with total thyroidectomy to rescue a case of thyroid storm intolerant to antithyroid drugs | |
| CN106902119B (zh) | 枸橼酸托法替布在治疗多发性大动脉炎药物中的应用 |